Terbinafine HCl; Lamisil AT; Terbinafina; Terbinafinum; UNII-012C11ZU6G; Zabel; Terbinafine (hydrochloride); C21H26ClN; CPD000469152; 012C11ZU6G; MFCD00145430; 78628-80-5 (HCl); Lamisil Krem; Terbinafine hydrochloride, 99%; Terbinafinum [Latin]; Terbinafina [Spanish]; Athletes foot; MycoVa; SF 86-327 hydrochloride; SMR000469152; DRG-0286; Terbisil; Afogan; TerbiFoam; InnoNyx; Lamisil (TN); Terbinafine hydrochloride [USP:JAN]; N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine hydrochloride; Terbinafine,hydrochloride; Terbinafine HCl (Lamisil); EC 616-640-4; terbinafine monohydrochloride; SCHEMBL36793; SCHEMBL36795; MLS001066620; MLS001304037; MLS001401424; Terbinafine Hydrochloride,(S); CHEMBL1200832; DTXSID90229223; HTU-520; Pharmakon1600-01505392; Terbinafine hydrochloride, >=98%; Terbinafine hydrochloride (Lamisil); AC-761; CT0259; NSC759113; s2557; SBB066075; AKOS015844100; AKOS025149216; Terbinafine hydrochloride (JP17/USP); AB03963; BCP9000834; CCG-101026; CS-1123; KS-1289; NC00276; NSC-759113; HY-17395; SC-14146; SF-86327; AB0013345; NM-100060; B2047; D2049; SW197656-2; D02219; J10383; W-5081; 628T805; A839463; Q-201790; Q27147212; Terbinafine hydrochloride, Antibiotic for Culture Media Use Only; Terbinafine hydrochloride, European Pharmacopoeia (EP) Reference Standard; (2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine hydrochloride; (2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-aminium chloride; Terbinafine hydrochloride, United States Pharmacopeia (USP) Reference Standard